Entasis Antibiotic Indication Changed Ahead Of FDA Panel, Ending Quest For First Pathogen-Specific Approval

 
• By Sarah Karlin-Smith
lungs
FDA’s Antimicrobial Drugs Advisory committee will vote on Entasis’ antibiotic for two types of pneumonia 17 April. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers